Vital Science

A medic by trade, Mark Kotter has always held a particular interest in neuroscience and stem cell research.As founder and CEO of bit.bio, he's overseen the development of a unique approach to "reprogram" stem cells and change them into consistent and scalable disease-relevant cells, which can then be screened for potential therapeutics to help treat such diseases as Huntington's Alzheimer's, and ALS.Hear about this revolutionary technology and how it works, what benefits it can provide researchers, and how it could very well shape the future of drug development.Show Notes  Stem Cells for Drug Discovery  Building a Stable of Stem Cells  Conversations in Science With Disruptors Leading the Way  Neuroscience | Charles River  bit.bio  Resources  https://www.bit.bio/news/focus-on-a-founder-with-mark-kotter-celebrating-10-years-of-community  https://www.criver.com/eureka/podcast/e28-building-the-building-blocks-of-life   https://www.criver.com/about-us/disruptors/meet-mark?region=3601  https://www.bit.bio/